Top analysts identify high growth biotech stocks and technology ETFs as strategic buys amid Middle East tensions

Wall Street analysts highlight Corbus Pharmaceuticals and AI infrastructure ETFs as top buy recommendations to hedge against current market volatility.

By: AXL Media

Published: Apr 3, 2026, 5:06 PM EDT

Source: The information in this article was sourced from TipRanks

Biotech Sector Emerges as High Upside Frontier

The biotechnology sector is currently commanding significant attention from top tier analysts, with clinical stage companies showing substantial projected growth. Corbus Pharmaceuticals has emerged as a primary focus, as Mizuho Securities recently increased its price target for the firm to 40 dollars per share. Analysts note that the company’s dual focus on cancer treatments and obesity medications positions it favorably within two of the most lucrative areas of modern medicine. With a unanimous buy rating from leading experts, the stock is currently estimated to have a potential 12 month upside exceeding 300 percent.

Expanding Reach in Wireless Infrastructure and Solid Tumors

Beyond obesity and oncology, analysts are highlighting Aviat Networks and Context Therapeutics as critical additions to growth oriented portfolios. Aviat Networks, a provider of wireless transport solutions, maintains a strong buy consensus with a price target of 38 dollars, reflecting optimism in the continued expansion of global networking infrastructure. Simultaneously, Context Therapeutics is gaining traction for its work in developing targeted therapies for solid tumors. LifeSci Capital analysts have maintained a buy rating on the stock, suggesting that the clinical stage developer could see its valuation nearly double as its therapeutic pipeline matures.

Strategic Hedging Through Diversified Technology Funds

As geopolitical tensions in the Middle East continue to pressure global stock markets, financial experts are recommending technology exchange traded funds as a method to mitigate company specific risks. These funds allow investors to gain exposure to high growth themes, such as artificial intelligence and cloud computing, without the volatility associated with individual stock picks. By diversifying across multiple tech leaders, these ETFs provide a buffer against the sudden pullbacks currently affecting the broader market. Analysts suggest that the recent dip in tech valuations represents an attractive entry point for long term investors.